Verona Pharma (VRNA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct6

Merck's Approximately $10 Billion Acquisition of Verona Pharma Approved by the High Court of England and Wales

21:00

Sep24

Verona Pharma Reaches Final Acquisition Agreement with Merck

21:02

Aug7

Verona Pharma released FY2025 Semi-Annual earnings on August 6 (EST), actual revenue USD 179.39 M, actual EPS USD -0.08

03:00

Verona Pharma released FY2025 Q2 earnings on August 6 (EST), actual revenue USD 103.14 M (forecast USD 93.9 M), actual EPS USD 0.1391 (forecast USD -0.066)

03:00

Aug6

Verona Pharma Beats Earnings Estimates

17:11

Verona Pharma Director Christina Ackermann Sells Company Shares

10:16

Schedules & Filings

Schedules

Filings

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 103.14 M, Net Income 11.92 M, EPS 0.1391

Apr29

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 76.26 M, Net Income -16.32 M, EPS -0.1921

Feb27

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 36.66 M, Net Income -33.83 M, EPS -0.4406

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More